Jagsonpal Pharmaceuticals announces acquisition of Aequitas Healthcare
Jagsonpal Pharmaceuticals Limited, a listed entity on NSE, announced the acquisition of Aequitas Healthcare Private Limited via formal press release dated 29 June 2026, disclosed to the exchange. The acquisition was notified to NSE via the corporate filing portal. Specific deal valuation, consideration structure, payment mechanics, and conditions precedent have not been disclosed in publicly available reporting or regulatory filings examined.
Why it mattersPharma M&A announcements via NSE disclosure require parallel verification via stock exchange filings, regulatory approvals (CCI for concentration review), and company press releases; absence of corroborating sources suggests deal remains early-stage or terms are being finalized.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Corporate Filing (Jagsonpal Pharmaceuticals) · official
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026